Design Therapeutics Inc.
DSGN | NASDAQ
$12.93
+$0.38 (+3.03%)
Sep 22, 2026, 12:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -20.17M | -17.64M | -16M | -17M | -19.08M | -17.72M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.07M | -11.32M | -7.64M | -5.51M |
Depreciation & Amortization | 151K | 157K | 156K | 155K | 152K | 159K | 149K | 153K | 151K | 143K | 138K | 137K | 133K | 129K | 124K | 108K | 92K | 82K | 82K | 31K | 12K | 4K |
Stock-Based Compensation | 3.87M | 3.92M | 3.44M | 3.59M | 3.99M | 3.54M | 3.47M | 3.12M | 3.3M | 3.18M | 2.72M | 3.22M | 3.72M | 3.43M | 3.08M | 2.87M | 2.62M | 2.36M | 1.56M | 1.24M | 1.24M | 647K |
Other Working Capital | -391K | -287K | -880K | 459K | 452K | -1.41M | 605K | 660K | -628K | -411K | 823K | -639K | 598K | 1.19M | -471K | -1.9M | 217K | -1.24M | 201K | 471K | -1.63M | -60K |
Other Non-Cash Items | 59K | -78K | -520K | -774K | -489K | -1.06M | -1.44M | -1.46M | -1.57M | -1.73M | -1.83M | -1.7M | -1.39M | -1.13M | -888K | -444K | -33K | 33K | 40K | 30K | 22K | -150K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 564K | -2.8M | 960K | 2.86M | 994K | -1.71M | 1.61M | 1.68M | -1.35M | -2.93M | -1.99M | -400K | 3.67M | -553K | -63K | 1.27M | 1.82M | -1.04M | 160K | 1.85M | -1.93M | 1.32M |
Operating Cash Flow | -15.52M | -16.43M | -11.97M | -11.16M | -14.44M | -16.79M | -9.86M | -9.55M | -11.26M | -12.44M | -12.8M | -14.53M | -13.8M | -17.42M | -15.09M | -13.9M | -10.5M | -11.83M | -9.23M | -8.16M | -8.29M | -3.7M |
Capital Expenditures | -21K | n/a | -34K | n/a | -87K | -72K | n/a | 16K | -161K | -195K | -27K | -53K | -89K | -87K | -288K | -310K | -244K | -76K | -354K | -968K | -183K | -33K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.82K | n/a | n/a | 39K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -12.42M | -52.59M | -87.62M | -78.08M | -39.53M | -86.55M | -64.37M | -66.51M | -53.63M | -45.66M | -74.15M | -54.57M | -62.37M | -33.62M | -61.01M | -94.01M | -157.98M | n/a | -49.91M | -4.32M | -26.93M | -5.11M |
Sales Maturities Of Investments | 27.5M | 45M | 76.08M | 84.59M | 59.74M | 94.49M | 66.21M | 60.67M | 81.13M | 66.47M | 79.74M | 69.89M | 74.44M | 53.44M | 60.24M | 30.94M | 1.23M | 490K | 200K | 245K | 5.54M | 28.17M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 15.06M | -7.59M | -11.58M | 6.51M | 20.12M | 7.87M | 1.83M | -5.83M | 27.33M | 20.62M | 5.56M | 15.27M | 11.98M | 19.73M | -1.06M | -63.39M | -156.96M | 414K | -50.06M | -5.04M | -21.57M | 23.03M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 605K | 19.93M | 25.32M | 37K | 361K | 23K | 263K | 1K | 229K | 20K | 501K | 13K | 210K | n/a | 130K | 151K | 225K | 156K | 193K | 30K | 5K | 378.98M |
Net Cash Flow | 137K | -4.09M | 1.77M | -4.62M | 6.04M | -8.9M | -7.77M | -15.37M | 16.3M | 8.2M | -6.74M | 745K | -1.61M | 2.31M | -16.02M | -77.14M | -167.66M | -11.26M | -59.09M | -13.18M | -29.86M | 398.31M |
Free Cash Flow | -15.55M | -16.43M | -12M | -11.16M | -14.53M | -16.86M | -9.86M | -9.53M | -11.42M | -12.63M | -12.83M | -14.59M | -13.89M | -17.51M | -15.38M | -14.21M | -10.74M | -11.9M | -9.58M | -9.13M | -8.47M | -3.73M |
Adj. Free Cash Flow | -19.41M | -20.36M | -15.44M | -14.75M | -18.51M | -20.4M | -13.33M | -12.65M | -14.72M | -15.82M | -15.55M | -17.81M | -17.61M | -20.94M | -18.46M | -17.08M | -13.36M | -14.26M | -11.14M | -10.38M | -9.72M | -4.38M |
Maintenance CapEx | -21K | n/a | -34K | n/a | -87K | -72K | n/a | 16K | -161K | -195K | -27K | -53K | -89K | -87K | -288K | -310K | -244K | -76K | -354K | -968K | -183K | -33K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -15.55M | -16.43M | -12M | -11.16M | -14.53M | -16.86M | -9.86M | -9.53M | -11.42M | -12.63M | -12.83M | -14.59M | -13.89M | -17.51M | -15.38M | -14.21M | -10.74M | -11.9M | -9.58M | -9.13M | -8.47M | -3.73M |
Add to Watchlist
Select watchlists to add or remove DSGN